Jump to:
Nicholas (Nick) Cheung is an associate in the corporate department in Hong Kong.
Nick advises clients on cross-border mergers and acquisitions, equity and debt financings, joint ventures, capital markets transactions and general corporate matters involving private equity and venture capital investors and multinational life science companies.
Prior to joining Ropes & Gray, Nick worked at another leading international law firm in its Hong Kong and New York offices, where he represented investment banks and companies on initial public offerings, debt offerings, mergers and acquisitions and securities compliance in Hong Kong.
Experience
- Advised LianBio in its divestiture of its exclusive rights to develop and commercialize Mavacamten in certain territories to Bristol Myers Squibb for up to US$350 million.
- Advised Cohen & Company Capital Markets, acting as lead financial and capital markets advisor of ExcelFin Acquisition Corp. in a business combination agreement with China-based Baird Medical, representing an implied pro forma enterprise value of approximately US$370 million for the combined company.
- Advised Everest Medicines in its divestiture of its exclusive rights to develop and commercialize Trodelvy in certain territories to Gilead Sciences, Inc. for up to US$455 million.
- Advised venture capital investors and life sciences companies on venture financing transactions and structuring strategic initiatives ranging from licensing, joint ventures, procurement and other commercial transactions.
- Advised venture capital investors and alternative asset managers on numerous Hong Kong IPO cornerstone investments and subsequent sell-down in companies in the TMT, healthcare, biotech and medical devices sectors.
- Advised companies listed on the Main Board of the Hong Kong Stock Exchange on securities compliance.
Notable transactions in which Nick has been involved prior to joining the firm include:
Mergers & Acquisitions
- Advised a fintech company in connection with its US$1.3 billion series C fundraise
- Advised a private company in connection with its proposed acquisition of an insurance arm of a leading global insurance company
- Advised a company listed on the Hong Kong Stock Exchange in connection with its US$90 million proposed acquisition of interest in a private company
Equity Capital Markets
- Advised 51 Credit Card, Inc. on its HK$1.0 billion initial public offering on the Main Board of the Hong Kong Stock Exchange
- Advised a placing agent in connection with the placing of shares of a listed company on the Hong Kong Stock Exchange for a total consideration of approximately HK$574 million
- Advised China Cinda Asset Management Co., Ltd. on its placing of new H shares to COSCO Shipping Financial Holdings Co., Limited for an aggregate consideration of approximately RMB5.49 billion
- Advised Postal Savings Bank of China Co., Ltd. on its HK$56.6 billion initial public offering on the Main Board of the Hong Kong Stock Exchange (awarded Global Finance Deal of the Year: Capital Markets (Equity) by American Lawyer, Equity Market Deal of the Year by Asian Legal Business, Deal of the Year by China Business Law Journal and Equity Deal of the Year by IFLR Asia)
- Advised China International Capital Corporation Limited on its HK$5,485.2 million initial public offering on the Main Board of the Hong Kong Stock Exchange (awarded Equity Deal of the Year by IFLR Asia)
Debt Capital Markets
- Advised Tencent Holdings Limited in connection with its US$2.5 billion the Rule 144A and Regulation S notes offering
- Advised CNOOC Limited in connection with its US$3.8 billion SEC-Registered guaranteed notes offering
- Advised CNOOC Limited in connection with its US$4.0 billion SEC-Registered guaranteed notes offering (awarded Deal of the Year by China Business Law Journal)
- Advised Zhongsheng Group Holdings Limited on its repurchase of HK$2.35 billion convertible bonds due 2018 and issuance of HK$4.7 billion convertible bonds due 2023
- Advised the initial purchasers in connection with a number of offerings of guaranteed senior notes issued by Oceanwide Holdings International 2017 Co., Limited
- Advised the initial purchasers in connection with a US$250 million Regulation S only offering by Hong Seng Limited of its 7.875% guaranteed senior notes due 2020
- Advised the initial purchasers in connection with a US$225 million Regulation S only offering by Times Property Holdings Limited of its 12.625% guaranteed senior notes due 2019
- Advised Greenland Hong Kong Holdings Limited in connection with a number of its notes offering
- Advised the initial purchasers in connection with a US$600 million Regulation S only offering by KWG Property Holding Limited of its 8.975% guaranteed senior notes due 2019
- Advised China Vanke Co., Ltd. in connection with a number of its guaranteed notes offering